feed,title,long_url,short_url
Benzinga,Second Setback For Incyte's LIMBER Program - Analyst Says 'Resolution Timelines Unclear To Assess Impact',https://benzinga.com/general/biotech/23/03/31492989/second-setback-for-incytes-limber-program-analyst-says-resolution-timelines-unclear-to-assess-imp,https://da.gd/4Q3kZ6
Benzinga,"Charles Schwab Shares Down 32% In March, Analysts Still See 'Downside To Valuation'",https://benzinga.com/analyst-ratings/analyst-color/23/03/31492873/charles-schwab-shares-down-32-in-march-analysts-still-see-downside-to-valuation,https://da.gd/v6R0s
Benzinga,"Juul Is Divested - Altria Now Focuses On Development Efforts For Smoke-Free Products, Updates 2028 Goals",https://benzinga.com/news/large-cap/23/03/31492174/juul-is-divested-altria-now-focuses-on-development-efforts-for-smoke-free-products-updates-2028-go,https://da.gd/ee15xb
